2CUREX vs NOVO-B: Side-by-Side Comparison
Compare 2cureX AB (2CUREX) and Novo Nordisk A/S (NOVO-B) side by side: market cap SEK 46.39M vs DKK 1.39T. Financials, growth and model signals on Bullrun.
| Metric | 2CUREX | NOVO-B |
|---|---|---|
| Company | 2cureX AB | Novo Nordisk A/S |
| Country / Exchange | Denmark · ST | Denmark · CO |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - General |
| Market cap | SEK 46.39M | DKK 1.39T |
| P/E ratio | — | 11.5 |
| Dividend yield | — | 5.00% |
| Valuation model | — | 21.7% undervalued |
| Revenue (latest FY) | SEK 0 | DKK 309.06B |
| Revenue growth YoY | — | +6.4% |
| Net income | SEK -4.55M | DKK 102.43B |
| Gross margin | — | 81.0% |
| Diluted EPS | -0.18 | 23.03 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.